Endocrine oncology

The Multi-Institutional Medullary Thyroid Cancer Collaborative Registry: Can a Rare Tumor Registry Accurately Represent the Real-World Patient Population?

ThyroidPublished Cross-sectional study

Authors' conclusion

The clinicodemographic profile of patients with MTC enrolled in a multi-institutional registry differs from those enrolled in population-based databases, with lower proportions of Hispanic and Black patients but additive data on treatment modalities.

Study context

Population
Medullary thyroid cancer (MTC) patients enrolled in Medullary Thyroid Cancer Collaborative Registry (MTCCoRe), Texas Cancer Registry (TCR), California Cancer Registry (CCR) and Surveillance, Epidemiology and End Results (SEER), 1995–2018
Participants
1,416 / 329 / 2,105 / 3,820
Exposure
MTCCoRe vs TCR, CCR and SEER
  • MTCCoRen = 1,416
  • TCRn = 329
  • CCRn = 2,105
  • SEERn = 3,820
Outcome
Demographic and clinical characteristics
Methodological detailsmulti-institutional registry compared with population-based cancer registries
  • Multi-institutional registry compared with population-based cancer registries

Main finding

As reported in the abstract

Age 20-54 years: MTCCoRe 58.0%, TCR 50.2%, CCR 47.2%, SEER 44.8%
p < 0.0001
Female: MTCCoRe 55.9%, TCR 61.4%, CCR 59%, SEER 57.5%
p = 0.3
Hispanic and Black: MTCCoRe 10.1% and 3.8%, TCR 23.7% and 8.2%, CCR 24.8% and 4.9%, SEER 15.9% and 8.2%
p < 0.001
T3-4 and N1: MTCCoRe 28.6% and 49.4%, TCR 12.7% and 32.2%, CCR 18.6% and 32.4%, SEER 24% and 37.8%; more advanced T and N in MTCCoRe
p < 0.0001
M1 disease: MTCCoRe 10%, TCR 11.9%, CCR 14.1%, SEER 9.5%
p < 0.0001

Observational data: associations, not effects.

Further findings

OutcomeMTCCoReTCRCCR
Systemic therapy11.4%0.3%5.6%

Original publication

The Multi-Institutional Medullary Thyroid Cancer Collaborative Registry: Can a Rare Tumor Registry Accurately Represent the Real-World Patient Population? Thyroid. Published 26 July 2024. doi:10.1089/thy.2024.0239

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.